跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 75 条关于
“osteoclast”
全部
75
临床试验
33
药物
5
机构
0
资讯
37
去年
Inflammation and Oxidative Stress Drive Osteoporosis Through Disrupted Bone Remodeling
去年
Gut Microbiota Emerges as Key Therapeutic Target for Osteoporosis Through Novel Gut-Bone Axis
2年前
EMA Validates Marketing Applications for HLX14 Denosumab Biosimilar in Osteoporosis Treatment
去年
FDA Accepts Biosimilar Applications for Denosumab from Organon and Teva
去年
āshibio Licenses Vantictumab for Rare Bone Disease ADO2 in Strategic Pipeline Expansion
去年
EMA Accepts Alvotech's Biosimilar AVT03 for Prolia and Xgeva
去年
Teva's Denosumab Biosimilar Candidate Accepted for Review by FDA and EMA
去年
HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles
11个月前
Sōlaria Biō's Bondia™ Demonstrates 85% Improvement in Bone Density Through Novel Gut-Bone Axis Targeting
去年
FDA Accepts Biosimilar Applications for Denosumab from Organon and Teva
第 1 页,共 4 页
上一页
下一页